Trial intelligence / Profile preview

Nitrosomonas Eutropha on Skin Nitrolipids

NCT02938650Phase 1Completed

Sponsor
University of California, Davis
Start
Oct 2016
Primary completion
May 2017
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of Nitrosomonas eutropha in dermatitis, sponsored by University of California, Davis. Primary endpoints: Alteration in microbiome diversity and species at 1 week and Alteration in nitrolipids in the skin at 1 week. Started Oct 2016; status: completed.

02

Drugs

Nitrosomonas eutropha
03

Conditions

dermatitis

Beyond the preview

Go deeper on NCT02938650.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02938650.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call